Clinical trial
Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis
NCT00004794 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004794 |
|---|---|
| Title | Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Northwestern University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cytomegalovirus Retinitis, Acquired Immunodeficiency Syndrome |
| Intervention type | Drug |
| Interventions | cidofovir |
| Enrollment | 90 |
| Start date | Mar 1, 1995 |
| First posted | Feb 25, 2000 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: